← Back to Search

Behavioural Intervention

HealthBeacon Injection Care Management System (ICMS) Arm for Respiratory Diseases

N/A
Waitlist Available
Led By Brian Modena, Dr
Research Sponsored by HealthBeacon Plc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial assesses the suitability of HealthBeacon ICMS for respiratory patients, to help them manage their medications at home and increase adherence.

Eligible Conditions
  • Respiratory Diseases

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Outcome of billing for the HealthBeacon Injection Care Management System (ICMS) under Remote Therapeutic Monitoring (RTM) reimbursement codes
Secondary outcome measures
Compliance Data
Participant Feedback
Physician Feedback

Trial Design

1Treatment groups
Experimental Treatment
Group I: HealthBeacon Injection Care Management System (ICMS) ArmExperimental Treatment1 Intervention
All participants enrolled will be recruited to this study arm and provided with access to the HealthBeacon ICMS.

Find a Location

Who is running the clinical trial?

HealthBeacon PlcLead Sponsor
1 Previous Clinical Trials
150 Total Patients Enrolled
Modena Allergy & AsthmaUNKNOWN
Brian Modena, DrPrincipal InvestigatorPrincipal Investigator

Media Library

HealthBeacon Injection Care Management System (ICMS) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05592769 — N/A
Respiratory Diseases Research Study Groups: HealthBeacon Injection Care Management System (ICMS) Arm
Respiratory Diseases Clinical Trial 2023: HealthBeacon Injection Care Management System (ICMS) Highlights & Side Effects. Trial Name: NCT05592769 — N/A
HealthBeacon Injection Care Management System (ICMS) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592769 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there space available for participants in this trial?

"Affirmative. Clinicaltrials.gov presents evidence that this experiment is actively seeking volunteers, having first been posted on November 1st 2022 and last updated 28 days later. A total of 10 candidates are needed at a single study site."

Answered by AI

To what extent is this study recruiting participants?

"Affirmative. On clinicaltrials.gov, the information points to this trial's active recruitment of participants starting from November 1st 2022 and ending on November 28th 2022; 10 individuals are being sought after at a single medical center."

Answered by AI
~4 spots leftby Apr 2025